Pharmacokinetic-Pharmacodynamic Determinants of Clinical Outcomes for Rifampin-Resistant Tuberculosis: A Multisite Prospective Cohort Study

BACKGROUND: Rifampin-resistant and/or multidrug-resistant tuberculosis (RR/MDR-TB) treatment requires multiple drugs, and outcomes remain suboptimal. Some drugs are associated with improved outcome. It is unknown whether particular pharmacokinetic-pharmacodynamic relationships predict outcome. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Heysell, Scott K, Mpagama, Stellah G, Ogarkov, Oleg B, Conaway, Mark, Ahmed, Shahriar, Zhdanova, Svetlana, Pholwat, Suporn, Alshaer, Mohammad H, Chongolo, Anna M, Mujaga, Buliga, Sariko, Margaretha, Saba, Sabrina, Rahman, S M Mazidur, Uddin, Mohammad Khaja Mafij, Suzdalnitsky, Alexey, Moiseeva, Elena, Zorkaltseva, Elena, Koshcheyev, Mikhail, Vitko, Serhiy, Mmbaga, Blandina T, Kibiki, Gibson S, Pasipanodya, Jotam G, Peloquin, Charles A, Banu, Sayera, Houpt, Eric R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907514/
https://www.ncbi.nlm.nih.gov/pubmed/35731948
http://dx.doi.org/10.1093/cid/ciac511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907514/
https://www.ncbi.nlm.nih.gov/pubmed/35731948
http://dx.doi.org/10.1093/cid/ciac511

Ejemplares similares